Strategic Financial Concepts LLC Invests $3.43 Million in The Clorox Company (NYSE:CLX)

Strategic Financial Concepts LLC bought a new stake in The Clorox Company (NYSE:CLX) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 21,107 shares of the company’s stock, valued at approximately $3,428,000.

Several other institutional investors have also recently bought and sold shares of CLX. State Street Corp grew its stake in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after acquiring an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC grew its position in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC grew its position in Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after purchasing an additional 33,970 shares in the last quarter. Stifel Financial Corp increased its stake in Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after buying an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp lifted its position in Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after buying an additional 31,510 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.6 %

Shares of CLX stock opened at $148.51 on Monday. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a market capitalization of $18.38 billion, a PE ratio of 40.58, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The firm has a 50 day moving average price of $161.06 and a two-hundred day moving average price of $158.88. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the company posted $2.16 earnings per share. As a group, analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analysts Set New Price Targets

A number of research firms recently issued reports on CLX. DA Davidson lowered their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, Evercore ISI increased their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.